Imaging techniques in the management and prevention of posttherapeutic upper limb edemas

Cancer

Volumn 83, Issue 12 SUPPL. II, 1998, Pages 2805-2813

  Bourgeois, Pierre ^a,c   Leduc, Oliver ^b   Leduc, Albert ^b  

^a JULES BORDET INSTITUTE   (Belgium)

^b FREE UNIVERSITY OF BRUSSELS   (Belgium)

^c SAINT PIERRE UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Axillary node; Breast carcinoma; Imaging; Lymphoscintigraphy; Sentinel node; Upper limb edema

Indexed keywords

ARM EDEMA; AXILLARY LYMPH NODE; BREAST CARCINOMA; CONFERENCE PAPER; DIAGNOSTIC IMAGING; DOPPLER ECHOGRAPHY; HUMAN; LYMPH NODE DISSECTION; LYMPHOSCINTIGRAPHY; POSITRON EMISSION TOMOGRAPHY; POSTOPERATIVE COMPLICATION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL;

EID: 0032534857     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1097-0142(19981215)83:12b+<2805::aid-cncr30>3.0.co;2-f     Document Type: Conference Paper

References (75)

1. Bruneton JN, Caramella E, Hery M, Aubanel D, Manzino JJ, Picard JL. Axillary lymph node metastases in breast cancer: preoperative detection with US. Radiology 1986;158:325-6.
2. Tate JJT, Lewis V, Arehcer T, Guyer PG, Royle T, Taylor I. Ultrasound detection of axillary nodes metastases in breast cancer. Eur J Surg Oncol 1989;15:139-41.
3. Ernst R, Weber A, Bauer KH, Friemann J, Zumtobel V. Perioperative ultrasound imaging of the breast in breast cancer. Zentrabl Chir 1990;115:963-75.
4. De Freitas R Jr., Costa MV, Schneider SV, Nicolau MA, Marussi E. Accuracy of ultrasound and clinical examination in the diagnosis of axillary node metastases in breast cancer. Eur J Surg Oncol 1991;17:240-4.
5. Tohnosu N, Okuyama K, Koide Y, Kikuchi T, Awano T, Matsubara H, et al. A comparison between ultrasonography and mammography, computed tomography and digital subtraction angiography for the detection of breast cancers. Surg Today 1993;28:704-10.
6. Walsh JS, Dixon JM, Chetty U, Paterson D. Colour doppler studies of axillary nodes metastases in breast carcinoma. Clin Radiol 1994;49:189-91.
7. Vaidya JS, Vyas JJ, Thakur MH, Khandelwal KC, Mittra I. Role of ultrasonography to detect axillary node involvement in operable breast cancer. Eur J Surg Oncol 1996;22:140-3.
8. Hergan K, Raid A, Zimmermann G, Oser W. Preoperative axillary ultrasound in breast carcinoma: value of the method in clinical practice. Ultraschall Med 1996;17:14-7.
9. Bonnema J, VanGeel AN, VanOoijen B, Mali SP, Tjian SL, Henzen-Logmans SC, Schmitz PI, Wiggers T. Ultrasound guided aspiration biopsy for detection of non palpable axillary node metastases in breast cancer patients: new diagnostic method. World J Surg 1997;21:270-4.
10. DeLand F, Kim E, Corgan R. Axillary lymphoscintigraphy in radio-immunodetection of carcino-embryogenic antigen in breast cancer" J Nucl Med 1979;20:1243-50.
11. Thompson CH, Stacker SA, Salehi N. Immunoscintigraphy for detection of lymph node metastases from breast cancer. Lancet 1984;2:1245-7.
12. Mandeville R, Pateisky N, Philipp K, Kubista E, Dumas F, Grouix B. Immunolymphoscintigraphy of axillary lymph node metastases in breast cancer patients using monoclonal antibodies: first clinical findings. Anticancer Res 1986;6: 1257-64.
13. Tjandra JJ, Russel IS, Collins JP, Andrews JT, Lichtenstein M, Bins D, MacKenzie IFC. Immunolymphoscintigraphy for the detection of lymph node metastases from breast cancer. Cancer Res 1989;49:1600-8.
14. Tjandra JJ, Sacks NPM, Thompson CH. The detection of axillary lymph node metastases from breast cancer by radiolabeled monoclonal antibodies: a prospective study. Br J Cancer 1989;59:291-302.
15. Kairemo KJA. Immunolymphoscintigraphy with 99mTc-labeled monoclonal antibody (BW431/26) reacting with carcinoembryonic antigen in breast cancer. Cancer Res 1990; 50:949-54.
16. Lamki LM, Buzdar AU, Singletary SL. Indium-111-labeled B72.3 monoclonal antibody in the detection and staging of breast cancer: a Phase I study. J Nucl Med 1991;32:1326-32.
17. Taylor JL, Taylor DL, Lowry C. Radioimmunoscintigraphy of metastatic breast carcinoma. Eur J Surg Oncol 1992;18:57-63.
18. Taillefer R, Robidoux A, Lambert R, Turpin S, Laperrière J. Technetium-99m sestamibi prone scintimammography to detect primary breast cancer and axillary node involvement. J Nucl Med 1995;36:1758-65.
19. Lamm WWM, Yang WT, Stewart IET, Metreweli C, King W. Detection of axillary lymph node metastases in breast carcinoma by technetium-99m sestamibi breast scintigraphy, ultrasound and conventional mammography. Eur J Nucl Med 1996;23:498-503.
20. Taillefer R, Robidoux A, Turpin S, Lambert R, Cantin J, Léveillé J. Metastatic axillary lymph node technetium-99m-MIBI imaging in primary breast cancer. J Nucl Med 1998;39: 459-64.
21. Adler LP, Crowe JP, Al-Kaisi NK, Sunshine JL. Evaluation of breast masses and axillary lymph nodes with 2-(Fluorine-18)-fluoro-2-deoxy-D-glucose PET. Radiology 1993;187:743-50.
22. Adler LP, Failhaber PF, Schnur KC, Al-Kasi NL, Shenk RR. Axillary lymph node metastases: screening with (F-18)2-deoxy-2-Fluoro-d-glucose (FDG) PET. Radiology 1997;203: 323-7.
23. Avril N, Dose J, Janicke F, Ziegler S, Romer W, Weber W, Herz M, Nathrath W, Graeff H, Schwaiger M. Assessment of axillary lymph node involvement in breast cancer patients with positron emission tomography using radiolabeled 2-(Fluorine-18)-fluoro-2-deoxy-D-glucose. J Natl Cancer Inst 1996;88:1204-9.
24. Holle LH, Trampert L, Lung-Kurt S, Villena-Heinsen CE, Pischel W, Schmidt S, Oberhausen E. Investigation of breast tumours with fluorine-18-fluorodeoxyglucose and SPECT. J Nucl Med 1996;37:615-22.
25. Crippa F, Agresti R, Seregni E, Greco M, Pascali C, Bogni A, Chiesa C, DeSanctis V, Delledonne V, Salvadori B, Leutner M, Bombardieri E. Prospective evaluation of Fluorine-18-FDG PET in presurgical staging of the axilla in breast cancer. J Nucl Med 1998;39:4-8.
26. Agwunobi TC, Boak JL. Diagnosis of malignant breast disease by axillary lymphoscintigraphy: a preliminary report. Br J Surg 1979;3:379-83.
27. Black RB, Merrick MV, Taylor TV. Prediction of axillary metastases in breast cancer by lymphoscintigraphy. Lancet 1980;2:15-17.
28. Christensen B, Blichert-Toft M, Siemssen OJ, Nielsen SL. Reliability of axillary lymph node scintiphotography in suspected carcinoma of the breast. Br J Surg 1980;67: 667-8.
29. Boak JL, Ingoldby CJH, Nathan BE, Meyers G. The role of axillary lymphoscintigraphy in the diagnosis of breast cancer. Clin Oncol 1981;7:45-52.
30. Black RB, Merrick MV, Taylor TV, Forrest APM. Lymphoscintigraphy cannot diagnose breast cancer. Br J Surg 1981; 68:145-6.
31. Gabelle P, Comet M, Bodin JP, Dupré A, Carpentier E, Bolla M, Swiercz P. Mammary lymphatic scintiscans by intratumoral injection in the assessment of breast cancer. Nouv Presses Med 1981;10:3067-70.
32. Osborne MP, Payna JH, Richardson VJ, McReady VR, Ryman BE. The preoperative detection of axillary lymph nodes metastases in breast cancer by isotope imaging. Br J Surg 1983; 70:141-4.
33. Hill NS, Ege GN, Greyson ND, et al. Predicting by lymphoscintigraphy of nodal metastases in breast cancer. Can J Surg 1983;26:507-9.
34. Mazzeo F, Accurso A, Petrella G, Capuano S, Maurelli L, Clenetano L, Squame G, Salvatore M. Preoperative axillary lymphoscintigraphy in breast cancer: experience with subareolar injection of 99mTc-nanocolloidal albumin. Nucl Med Comm 1986;7:5-16.
35. McLean RG, Ege GN. Prognostic value of axillary lymphoscintigraphy in breast carcinoma patients. J Nucl Med 1986; 27:1116-24.
36. Cabanas RM. An approach for the treatment of penile carcinoma. Cancer 1977;39:456-66.
37. Krag DN, Weaver DL, Alex JC, Fairbanks JT. Surgical resection and radiolocalization of the sentinel lymph nodes in breast cancer using a gamma probe. Surg Oncol 1993;2:335-40.
38. Albertini JJ, Lyman OH, Cox C, Yeatman T, Balducci L, Ku NN, Shivers S, Berman C, Wells K, Rapaport D, Shons A, Horton J, Greenberg H, Nicosia S, Clark R, Cantor A, Reintgen D. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA 1996;276:1818-22.
39. Giuliano A, Jones R, Brennan M, Statman R. Sentinel Lymphadenectomy in breast cancer. J Clin Oncol 1997;15: 2345-50.
40. Turner R, Ollilla D, Krasne D, Giuliano A. Histopathologic validation of the sentinel lymph node hypothesis for breast carcinoma. Ann Surg 1997;226:271-8.
41. Veronesi U, Paganelli G, Galimberti V, Viale G, Zurrida S, Bedoni M, Costa A, De Cicco C, Geraghty JG, Luini A, Sacchini V, Veronesi P. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymphnodes. Lancet 1997;349:1864-7.
42. El-Shirbiny AM, Yeh S, Cody HS, Borgen PI, Larson SM. Scintigraphic identification of sentinel lymph node in breast cancer [abstract]. Eur J Nucl Med 1997;24:892.
43. Gulec SA, Moffat FL, Serafini AN, Sfakianakis GN, Allen L, Boggs J, Escobedo D, Sundaram M, Boyle M, Livingstone A, Krag D. Sentinel node localization in patients with breast cancer [abstract]. J Nucl Med 1997;38:33P.
44. Pijpers R, Meijer S, Hoekstra OS, Collet GJ, Comans EF, Boom RP, VanDiest PJ, Teule JG. Impact of lymphoscintigraphy on sentinel node identification with technetium-99m-colloidal albumin in breast cancer. J Nucl Med 1997;38: 366-8.
45. Carena M, Baiardi P, Saponaro M, Mazzoieni MC, Rossi G, Paroni G, Aprile C. Scintigraphic evaluation of predisposition to post-mastectomy lymphedema. In: Progress in Lymphology XIII. Cluzan RV, et al., editors. Berlin: Springer-Verlag, 1992:325-6.
46. Pecking AP, Floiras JL, Rouessé J. Upper limb lymphedema's frequency in patients treated by conservative therapy in breast cancer. Lymphology 1996;29(Suppl):293-6.
47. Muller RP, Tillkorn H, Peters PE. Lymphography of the upper limb following radical axillary lymph node dissection" In: Progress in Lymphology. Weissleider H, Bartos V, Clodius L, Målek P, editors. Prague: Avicenum Czechoslovsk Medical Press, 1981:226-9.
48. Bourgeois P, Fruhling J, Henry J. Postoperative axillary lymphoscintigraphy in the management of breast cancer. Int J Radiat Oncol Biol Phys 1983;9:29-32.
49. Fruhling J, Bourgeois P. Axillary lymphoscintigraphy: current status in the treatment of breast cancer. CRC Crit Rev Oncol Hematol 1983;1:1-20.
50. Mattheiem W, Bourgeois P, Delcorde A, Stegen M, Fruhling J. Axillary dissection in breast cancer revisited. Eur J Surg Oncol 1989;15:490-5.
51. Bourgeois P. Les investigations lymphoscintigraphiques post-opératoires des chaînes mammaires internes et des creux axillaires dans le bilan et le pronostic des cancers du sein (the postoperative investigations of the axilla and of the internal mammary chains in the management and prognosis of breast carcinomas). Thèse d'Agrégation de l'Enseignement Supérieur, Faculté de Médecine, Université Libre de Bruxelles. Brussels, Belgium: 1997.
52. Kett K, Szilagyi K, Clodius L. The value of combined lymphography in the diagnosis of lymph node metastases in breast cancer. In: Progress in lymphology XIII. Excerpta medica. Cluzan RV, et al., editors. Amsterdam: Elsevier Science Publishers, 1992:371-2.
53. Pecking AP, Firmin F, Rain JD, Desprez-Curely JP, Cluzan RV, Jacquillat C, Banzet P. Lymphoedeme post-chirurgical et radiothérapique des membres supérieurs: exploration par la lymphographie isotopique indirecte (lymphedema of the upper limb following surgery or radiotherapy: investigation by indirect radioactive lymphography). Nouv Presse Méd 1980;9:3349-51.
54. Kaplan WD, Slavin SA, Markisz JA, Laffin SM, Royal HD. Qualitative and quantitative upper extremity radionuclide lymphoscintigraphy [abstract]. J Nucl Med 1983;24:40.
55. Carena M, Campini R, Zelaschi G, Rossi G, Aprile C, Paroni G. Quantitative lymphoscintigraphy. Eur J Nucl Med 1988; 14:88-92.
56. Weissleder H, Wielssleder R. Lymphedema: evaluation of qualitative and quantitative lymphoscintigraphy in 238 patients. Radiology 1988;167:729-35.
57. Cambria RA, Glovczki P, Naessens JA, Wahner HW. Noninvasive evaluation of the lymphatic system with lymphoscintigraphy: a prospective, semiquantitative analysis in 386 extremities. J Vasc Surg 1993;18:773-82.
58. Golucke PJ, Montgomery RA, Petronis JD, Minken SL, Peter BA, Williams GM. Lymphoscintigraphy to confirm the clinical diagnosis of lymphedema. J Vasc Surg 1989;10:306-12.
59. Kleinhans E, Baumeister RGH, Hahn D, Siuda S, Büll U, Moser E. Evaluation of transport kinetics in lymphoscintigraphy: follow-up study in patients with transplanted vessels. Eur J Nucl Med 1985;10:349-52.
60. Ter SE, Alavi A, Kim CK, Merli G. Lymphoscintigraphy: a reliable test for the diagnosis of lymphedema. Clin Nucl Med 1993;18:646-54.
61. De Groote M, Jonnart C, Puissant F, Buisset J, Schlikker E. Lymphoscintigraphic evaluation of the efficiency of manual lymphatic drainage. Eur J Lymphol Rel Prob 1992;3:85-7.
62. Verlooy H, Biscompte JP, Nieuborg L, Drent P, Schiepers C, Mortelmans L, De Roo M. Noninvasive evaluation of lymphovenous anastomosis in upper lymphedema: value of quantitative lymphoscintigraphic examinations. Eur J Lymphol Rel Probl 1997;6:27-33.
63. Weiss M, Baumeister RGH, Tatsch K, Hahn K. Lymphoscintigraphy and semiquantitative evaluation of lymph drainage for long-term follow-up in patients with autogenous lymph vessel transplantation. Eur J Lymphol Rel Probl 1997;6:34-37.
64. Ferrandez JC, Serin D, Vinot JM. Lymphoscintigraphic assessment of manual lymphatic drainage: report of 47 observations. Eur J Lymphol Rel Probl 1997;6:38-46.
65. Vaqueiro M, Glowiczki P, Fischer J, Hollier LH. Lymphoscintigraphy in lymphedema: an aid to microsurgery. J Nucl Med 1986;27:1125-30.
66. Ghabboun S, Alliot F, Cluzan RV, Pascot M. Venous disorders in secondary upper limb lymphedema. Lymphology (suppl) 1998;31:519-21.
67. Zanolla R, Blandini MG, Balzarini A, Feria F, Pirovano C. Breast cancer: oedema post-axillary dissection. Is Doppler flowmetry evaluation predictive for edema? Are there precautionary therapies after surgery? In: Progress in lymphology XIII. Cluzan RV, editors. Berlin: Springer-Verlag, 1992: 621-2.
68. Boccardo F, Tacchella M, Zilli A, Campisi C. Laser-Doppler evaluation in peripheral lymphedema. Lymphology (suppl) 1998;31:279-81.
69. Bruna J. Computerized tomography and xeroradiography in evaluation of oedemas. Eur J Lymphol Rel Probl 1991;2:1-4.
70. Unger EC, Baker MR. Role of magnetic resonance imaging in the evaluation of lymphedema and disease of the lymphatics. Lymphology 1994;27(Suppl):249-51.
71. Cluzan RV, Pecking A, Ruiz JC, Alliot F, Ghabboun S, Pascot M, Gachon-Lameyre V. Biphotonic aborbtiometry of the secundary upper limb lymphedema. Lymphology (suppl) 1998;31:296-8.
72. Bourgeois P. Nodal relapse(s) and lymphedema(s). In: Vascular medicine. Boccalon H, editor. Amsterdam: Elsevier Science Publisher, 1993:453-6.
73. Pecking A, Delorme G, Briere B. Exploration du lymphoedeme par les marqueurs biologiques [oral presentation]. Euromedicine, Montpellier, 1989.
74. McQuarrie SA, MacLean GD, Boniface GR, Golberg K, McEwan AJB. Radioimmunoscintigraphy in patients with breast adenocarcinoma using technetium-99-m labelled monoclonal antibody 170H.82: report of a Phase II study. Eur J Nucl Med 1997;24:381-9.
75. Moon DH, Maddahi J, Silverman DHS, Glaspy JA, Phelps ME, Hoh CK. Accuracy of whole-body fluorine-18-FDG PET for the detection of recurrent or metastatic breast cancer. J Nucl Med 1998;39:431-5.